|Description||The hydrobromide salt form of Dihydro-β-erythroidine, which is a competitive nAChR antagonist and has been found to show antagonizes behavioral effects of nicotine in vivo.|
|Purity||≥98% by HPLC|
CP-810123 is a novel alpha 7 nAChR agonist with potential treatment for cognitive deficits associated with psychiatric or neurological conditions including schi...
PHA 568487 is an orally active and brain penetrant agonist of the alpha 7 nicotinic acetylcholine receptor (Ki = 44 and 2800 for α7 and 5-HT3 respectively, IC50...
(+)-Anabasine hydrochloride is a nicotine alkaloid present in tobacco products. It is a high affinity neuronal nicotinic ACh receptor partial agonist with Ki va...
CP-601932 is a CNS-penetrant, high affinity, and selective α(4) β(2) nicotinic acetylcholine receptors partial agonist.
α-Conotoxin AuIB is a selective antagonist of α3β4 nicotinic acetylcholine receptors. It shows > 100-fold selectivity over other receptor subunit combinations.
The hydrochloride salt form of Procyclidine which has been found to be a muscarinic antagonist that could be effective against Parkinson's disease and some rela...
SIB 1553A hydrochloride
SIB 1553A hydrochloride is a nicotinic acetylcholine receptor (nAChR) agonist with selectivity for β4 subunit-containing receptors. It stimulates acetylcholine ...